SIOUX FALLS, S.D., Nov. 13, 2017 -- Raven Industries, Inc. (NASDAQ:RAVN) announced today that Mark Griffin will retire from the company’s Board of Directors effective December 4, 2017.
“Raven has benefited greatly from Mark’s leadership and guidance during his tenure on the board of directors,” said Marc LeBaron, Raven’s Chairman of the Board. “His business acumen, along with his deep understanding of the Raven culture, has been invaluable.”
Having served on the board since 1987, Mr. Griffin most recently chaired the Personnel & Compensation Committee.
“I’m honored to have served on the Raven board for 30 years,” said Griffin. “Watching the company grow and establish itself as an innovative, service-driven technology company has truly been a fulfilling experience. While I’m stepping down to concentrate on my business, Lewis Drug, and to serve on several drugstore industry boards, I believe Raven is well-positioned for success in the years to come.”
Raven Industries President and CEO Dan Rykhus stated, “We thank Mark for his wise counsel and many contributions throughout his long tenure. He has represented our shareholders well, and we will miss his leadership and perspective.”
The company’s board plans to select a suitable replacement to fill the vacancy in the coming weeks.
About Raven Industries, Inc.
Raven Industries (NASDAQ:RAVN) is dedicated to providing innovative, high-value products and solutions that solve great challenges throughout the world. Raven is a leader in precision agriculture, high-performance specialty films, and lighter-than-air technologies. Since 1956, Raven has designed, produced, and delivered exceptional solutions, earning the company a reputation for innovation, product quality, high performance, and unmatched service. For more information, visit http://ravenind.com.
Contact Information
Margaret Carmody, Director of Communications
Raven Industries, Inc.
+1 (605) 336-2750


Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Amazon Explores AI Content Marketplace With Media Publishers
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 



